Loading…

Bioventus amended its agreement to acquire CartiHeal, reducing the closing payment to $50 million and deferring $215 million into tranches, with the acquisition expected to close by end of July 2022.
“Bioventus amended the agreement for its pending acquisition of CartiHeal to defer a large chunk of payments.”massdevice.com
Summarized from public sources; check the original articles before acting on it.